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ABSTRACT 
 
Introduction: systemic lupus erythematosus (SLE) is a rheumatic autoimmune disease characterized 
by chronic inflammation that is associated with clinical symptoms and disease severity. Therefore, 
strategies to reduce inflammation, such as physical exercise, have a potential therapeutic role in SLE 
due to its anti-inflammatory effects. This study sought to compare cytokines and soluble TNF 
receptors response to: (1) moderate vs. intense aerobic exercise in active SLE (SLEACT) and remission 
SLE (SELREM) patients; (2) SLEACT vs. SLEREM patients undergoing moderate and intense aerobic 
exercises; and (3) SLE patients vs. healthy controls (HC) undergoing moderate and intense aerobic 
exercises. Methods: twelve SLEREM (age: 35.3±5.7 yrs; BMI: 25.6±3.4 kg/m2), 11 SLEACT (age: 30.4±4.5 
yrs; BMI: 26.1±4.8 kg/m2) and 10 age-and BMI-matched HC (age: 30.6±5.2 yrs; BMI: 24.1±2.3 kg/m2) 
performed 30-min sessions of moderate (~50% of VO2max) and intense (~70% of VO2max) exercises. 
Serum cytokines (INF-γ, IL-10, IL-6, TNF-α) and soluble receptors (sTNFR1 and sTNFR2) were 
measured at rest, immediately after the exercise, every 30-min during three hours of recovery, and 24 
h after the end of exercise session. Results: there were no differences for cytokines and sTNFRs 
responses between moderate and intense aerobic exercise for SLEACT and SLEREM patients (P>0.05). 
Similar responses were found when SLEACT and SLEREM patients were compared for moderate and 
intense exercises, except for 1) serum TNF-α, which was lower in SLEACT than SLEREM patients after 
moderate exercise (P<0.05); 2) serum sTNFR1, which was higher in SLEREM than SLEACT patients at 30th 
and 60th minutes of moderate exercise recovery (P=0.027 and P=0.036, respectively); and 3) serum 
sTNFR2, which remained higher during both sessions of exercise and recovery for SLEREM in 
comparison to SLEACT patients (P<0.01). Also, a time-effect was observed for serum IL-6 and TNF-α 
(P<0.05) after intense exercise with a posterior reduction under baseline values, reaching the values 
experienced by HC. Conclusion: cytokines and sTNFRs were not different in both exercise intensities 
for SLEACT and SLEREM, except for a few differences, which pointed out to a "less inflammatory 
pattern" in SLEACT patients, suggesting that exercise (even more intensive) can be safely performed by 
SLE patients with active disease. Finally, the reduction shown in serum IL-6 and TNF-α after intense 
exercise in SLEACT patients supports evidences for an anti-inflammatory effect of exercise and 
reinforces the importance of physical exercise to SLE treatment. 
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